$2.54T
Total marketcap
$193.21B
Total volume
BTC 49.92%     ETH 15.85%
Dominance

BioCryst Pharmaceuticals BCRX Stock

5.07 USD {{ price }} 1.400003% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
1.05B USD
LOW - HIGH [24H]
4.89 - 5.18 USD
VOLUME [24H]
3.76M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.18 USD

BioCryst Pharmaceuticals Price Chart

BioCryst Pharmaceuticals BCRX Financial and Trading Overview

BioCryst Pharmaceuticals stock price 5.07 USD
Previous Close 7.94 USD
Open 8 USD
Bid 0 USD x 1400
Ask 0 USD x 1800
Day's Range 7.9 - 8.04 USD
52 Week Range 7.2 - 15.43 USD
Volume 1.53M USD
Avg. Volume 2.61M USD
Market Cap 1.51B USD
Beta (5Y Monthly) 1.982746
PE Ratio (TTM) N/A
EPS (TTM) -1.18 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 15.15 USD

BCRX Valuation Measures

Enterprise Value 1.86B USD
Trailing P/E N/A
Forward P/E -14.777778
PEG Ratio (5 yr expected) -0.19
Price/Sales (ttm) 5.2046776
Price/Book (mrq) N/A
Enterprise Value/Revenue 6.438
Enterprise Value/EBITDA -14.875

Trading Information

BioCryst Pharmaceuticals Stock Price History

Beta (5Y Monthly) 1.982746
52-Week Change -17.047%
S&P500 52-Week Change 20.43%
52 Week High 15.43 USD
52 Week Low 7.2 USD
50-Day Moving Average 8.2 USD
200-Day Moving Average 10.57 USD

BCRX Share Statistics

Avg. Volume (3 month) 2.61M USD
Avg. Daily Volume (10-Days) 1.88M USD
Shares Outstanding 188.94M
Float 159.93M
Short Ratio 12.75
% Held by Insiders 1.07%
% Held by Institutions 87.07%
Shares Short 35.58M
Short % of Float 21.16%
Short % of Shares Outstanding 18.82%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -78.10%
Operating Margin (ttm) -43.80%
Gross Margin 15.90%
EBITDA Margin -43.27%

Management Effectiveness

Return on Assets (ttm) -15.28%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 289.68M USD
Revenue Per Share (ttm) 1.55 USD
Quarterly Revenue Growth (yoy) 37.79%
Gross Profit (ttm) 10.94M USD
EBITDA -125368000 USD
Net Income Avi to Common (ttm) -226252992 USD
Diluted EPS (ttm) -1.18
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 398.16M USD
Total Cash Per Share (mrq) 2.11 USD
Total Debt (mrq) 755.36M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 5.764
Book Value Per Share (mrq) -1.738

Cash Flow Statement

Operating Cash Flow (ttm) -131562000 USD
Levered Free Cash Flow (ttm) -114687000 USD

Profile of BioCryst Pharmaceuticals

Country United States
State NC
City Durham
Address 4505 Emperor Boulevard
ZIP 27703
Phone 919 859 1302
Website https://www.biocryst.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 531

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor for complement-mediated diseases; and Galidesivir, to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

Q&A For BioCryst Pharmaceuticals Stock

What is a current BCRX stock price?

BioCryst Pharmaceuticals BCRX stock price today per share is 5.07 USD.

How to purchase BioCryst Pharmaceuticals stock?

You can buy BCRX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for BioCryst Pharmaceuticals?

The stock symbol or ticker of BioCryst Pharmaceuticals is BCRX.

Which industry does the BioCryst Pharmaceuticals company belong to?

The BioCryst Pharmaceuticals industry is Biotechnology.

How many shares does BioCryst Pharmaceuticals have in circulation?

The max supply of BioCryst Pharmaceuticals shares is 206.15M.

What is BioCryst Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

BioCryst Pharmaceuticals PE Ratio is now.

What was BioCryst Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

BioCryst Pharmaceuticals EPS is -1.18 USD over the trailing 12 months.

Which sector does the BioCryst Pharmaceuticals company belong to?

The BioCryst Pharmaceuticals sector is Healthcare.

BioCryst Pharmaceuticals BCRX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
NASDAQ Biotechnology Total Retu XNBI 4654.3 USD
-0.65
4652.69 USD 4696.7 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Composite Total Return I XCMP 19565.06 USD
+0.82
19553.78 USD 19740.18 USD